Joint use of epidemiological and hospital medico-administrative data to estimate prevalence. Application to French data on breast cancer

Cancer Epidemiology

Volumn 36, Issue 2, 2012, Pages 116-121

  Colonna, Marc ^a,b   Mitton, Nicolas ^a   Schott, Anne Marie ^c,d   Remontet, Laurent ^c,e,f,g   Olive, Frédéric ^h   Gomez, Frédéric ⁱ   Iwaz, Jean ^c,e,f,g   Polazzi, Stéphanie ^c,d   Bossard, Nadine ^c,e,f,g   Trombert, Béatrice ^j  

^a Registre des Cancers de l'Isère   (France)

^b Réseau des Registres de Cancers FRANCIM   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITÉ DE LYON   (France)

^f UNIVERSITÉ LYON 1   (France)

^g LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁱ CENTRE LÉON BÉRARD   (France)

^j UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

more..

Author keywords

Breast neoplasms; Epidemiology; Health status indicators; Hospital information systems; Incidence; Prevalence; Registries

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; FEMALE; FRANCE; HOSPITAL INFORMATION SYSTEM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL;

EID: 84858798753     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.12.001     Document Type: Article

References (32)

1. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E., Delafosse P., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56:159-175.
2. Giles G. How important are estimates of cancer prevalence. Ann Oncol 2002, 13:815-816.
3. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. Epidemiol Prev 2010, 34:1-188. AIRTUM Working Group.
4. Engholm G., Ferlay J., Christensen N., Bray F., Gjerstorff M.L., Klint A., et al. NORDCAN - a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010, 49:725-736.
5. Howlader N., Noone A.M., Krapcho M., Neyman N., Aminou R., Waldron W., et al. SEER Cancer Statistics Review, 1975-2008 2011, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/.
6. Louwman W.J., Klokman W.J., Coebergh J.W.W. Excess mortality from breast cancer 20 years after diagnosis when life expectancy is normal. Br J Cancer 2001, 84:700-703.
7. Brenner H., Hakulinen T. Are patients diagnosed with breast cancer before age 50 years ever cured. J Clin Oncol 2004, 22:432-438.
8. Remontet L., Estève J., Bouvier A.M., Grosclaude P., Launoy G., Menegoz F., et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003, 51:3-30.
9. Trouessin G., Allaert F.A. FOIN: a nominative information occultation function. Stud Health Technol Inform 1997, 43(PtA):196-200.
10. Feldman A.R., Kessler L., Myers M.H., Naughton M.D. The prevalence of cancer (estimates based on the Connecticut Tumor Registry). N Engl J Med 1986, 315:1394-1397.
11. Curado M.P., Edwards B., Shin H.R., Storm H., Ferlay J., Heanue M., et al. Cancer incidence in five continents 2007, vol. IX. IARC Scientific Publications, Lyon, No. 160.
12. Esteve J., Benhamou E., Raymond L. Fundamental concepts. Descriptive epidemiology 1994, vol. IV:37-44. IARC Scientific Publications, Lyon, No. 128.
13. Day N. Cumulative rate and cumulative risk. Cancer in five continents 1992, vol. VI. IARC Scientific publication, No. 120 [chapter 9].
14. Coleman M.P., Esteve J., Damiecki P., Arslan A., Renard H Trends in cancer incidence and mortality 1993, IARC Scientific Publications, Lyon, No. 121.
15. Colonna M., Danzon A., Delafosse P., Mitton N., Bara S., Bouvier A.M., et al. Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012. Eur J Cancer 2008, 44:115-122.
16. Verdecchia A., Micheli A., Colonna M., Moreno V., Izarzugaza M.I., Paci E. A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. Ann Oncol 2002, 13:1128-1139.
17. Trombert Paviot B., Gomez F., Olive F., Polazzi S., Remontet L., Bossard N., et al. Identifying prevalent cases of breast cancer in the French case-mix databases. Methods Inf Med 2011, 50:124-130.
18. Complete prevalence: Surveillance, Epidemiology, and End Results (SEER) Program (). Prevalence database: US Estimated Complete Prevalence Counts on 1/1/2008. National Cancer Institute, DCCPS, Surveillance Research Program, Statistical Research and Applications Branch, released April 2011, based on the November 2010 SEER data submission. http://www.seer.cancer.gov/.
19. Surveillance, Epidemiology, and End Results (SEER) Program (). Prevalence database: US Estimated 33-Year L-D Prevalence Counts on 1/1/2008. National Cancer Institute, DCCPS, Surveillance Research Program, Statistical Research and Applications Branch, released April 2011, based on the November 2010 SEER data submission. http://www.seer.cancer.gov/.
20. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A. NORDCAN - Cancer incidence, mortality, prevalence and prediction in the Nordic Countries, Version 4. Association of the Nordic Cancer Registries. Danish Cancer Society, <>; 2011. http://www.ancr.nu/.
21. Baade P., Fritschi L., Eakin E. Non cancer mortality among people diagnosed with cancer (Australia). Cancer Causes Control 2006, 17:287-297.
22. Sarfati D., Blakely T., Pearce N. Measuring cancer survival in populations: relative survival vs cancer specific survival. Int J Epidemiol 2010, 39:598-610.
23. Micheli A., Mugno E., Krogh V., Quinn M.J., Coleman M., Hakulinen T., et al. Cancer prevalence in European registry areas. Ann Oncol 2002, 13:840-865.
24. Capocaccia R., De Angelis R. Estimating the completeness of prevalence based on cancer registry data. Stat Med 1997, 6:425-440.
25. Verdecchia A., Capocaccia R., Egidi V., Golini A. A method for the estimation of chronic disease morbidity and trend from mortality data. Stat Med 1989, 8:201-216.
26. Verdechhia A., De Angelis G., Capocaccia R. Estimation and projections of cancer prevalence from cancer registry data. Stat Med 2002, 21:3511-3526.
27. De Angelis G., De Angelis R., Frova L., Verdecchia A. Miamod: acomputer package to estimate chronic disease morbidity using mortality and survival data. Comput Methods Programs Biomed 1994, 44:99-107.
28. Coleman M., Quaresma M., Berrino F., Lutz J.M., De Angelis R., Capocaccia R., et al. cancer survival in five continents: a worldwide population based study. Lancet Oncol 2008, 9:730-756.
29. Pisani P., Bray F., Parkin D.M. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002, 97:72-81.
30. De Angelis R., Capocaccia R., Hakulinen T., Soderman B., Verdecchia A. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med 1999, 18:441-454.
31. Olive F., Gomez F., Schott A.M., Remontet L., Bossard N., Mitton N., et al. Analyse critique des données du PMSI pour l'épidémiologie des cancers: une approche longitudinale devient possible. Rev Epidemiol Sante Publique 2011, 59:53-58.
32. Connell F.A., Diehr P., Hart L.G. The use of large data bases in healthcare studies. Annu Rev Public Health 1987, 8:51-74.